{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:34:23Z","timestamp":1790015663669,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.jhep.2010.10.039","type":"journal-article","created":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T09:24:27Z","timestamp":1293096267000},"page":"435-444","source":"Crossref","is-referenced-by-count":95,"title":["Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis"],"prefix":"10.1016","volume":"55","author":[{"given":"Lisa","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan V.","family":"McLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaiya","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey W.","family":"McCaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Gorrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis K.","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Twigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2010.10.039_b0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1467-789X.2009.00657.x","article-title":"Non-alcoholic fatty liver disease from pathogenesis to management: an update","volume":"11","author":"Musso","year":"2010","journal-title":"Obesity Rev"},{"key":"10.1016\/j.jhep.2010.10.039_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","article-title":"Fatty liver: a novel component of the metabolic syndrome","volume":"28","author":"Kotronen","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2010.10.039_b0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MED.0b013e3283293015","article-title":"Non-alcoholic fatty liver disease in type 2 diabetes","volume":"16","author":"Cusi","year":"2009","journal-title":"Curr Opin Endocrinol Diabet Obes"},{"key":"10.1016\/j.jhep.2010.10.039_b0020","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: A Tale of Two: \u201cHits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.10.039_b0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-126-2-199701150-00008","article-title":"Nonalcoholic steatohepatitis","volume":"126","author":"Sheth","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2010.10.039_b0030","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.10.039_b0035","first-page":"S5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults","volume":"40","author":"Clark","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2010.10.039_b0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cld.2007.02.013","article-title":"Metabolic syndrome and NASH","author":"Marchesini","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2010.10.039_b0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pathophys.2008.04.003","article-title":"Risk factors and mechanisms of non-alcoholic steatohepatitis","volume":"15","author":"Rivera","year":"2008","journal-title":"Pathophysiology"},{"key":"10.1016\/j.jhep.2010.10.039_b0050","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","article-title":"Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.10.039_b0055","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.cgh.2009.06.007","article-title":"Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease","author":"Hossain","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.10.039_b0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2009.03.019","article-title":"Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis","volume":"51","author":"Argo","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.10.039_b0065","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.2337\/diabetes.52.8.1958","article-title":"Variation in type 2 diabetes \u2013 related traits in mouse strains susceptible to diet-induce obesity","volume":"52","author":"Rossmeisl","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2010.10.039_b0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0026-0495(95)90123-X","article-title":"Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL\/6J and A\/J mice","author":"Surwit","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2010.10.039_b0075","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/en.2004-0028","article-title":"Impaired glucose stimulated insulin secretion, enhanced intraperitoneal insulin tolerance, and increased beta-cell mass in mice lacking the p110gamma isoform of phosphoinositide 3-kinase","volume":"45","author":"MacDonald","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2010.10.039_b0080","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.2337\/diabetes.51.11.3211","article-title":"Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet","author":"Joseph","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2010.10.039_b0085","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcp\/28.1.56","article-title":"A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases","volume":"28","author":"Reitman","year":"1957","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jhep.2010.10.039_b0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/BF00316069","article-title":"Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil Red O","volume":"97","author":"Ramirez-Zacarias","year":"1992","journal-title":"Histochemistry"},{"key":"10.1016\/j.jhep.2010.10.039_b0095","doi-asserted-by":"crossref","first-page":"C740","DOI":"10.1152\/ajpcell.00333.2007","article-title":"Connective tissue growth factor inhibits adipocyte differentiation","volume":"295","author":"Tan","year":"2008","journal-title":"Am J Physiol \u2013 Cell Physiol"},{"key":"10.1016\/j.jhep.2010.10.039_b0100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jhep.2010.10.039_b0105","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1210\/en.2004-0436","article-title":"Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy","volume":"145","author":"McLennan","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2010.10.039_b0110","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1210\/en.2003-0967","article-title":"Connective tissue growth factor is up-regulated in the diabetic retina: amelioration by angiotensin-converting enzyme inhibition","volume":"145","author":"Tikellis","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2010.10.039_b0115","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1210\/endo.143.4.8741","article-title":"Connective tissue growth factor\/IGF-binging protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts","volume":"143","author":"Twigg","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2010.10.039_b0120","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jdiacomp.2007.07.001","article-title":"Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy","volume":"22","author":"Thomson","year":"2008","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jhep.2010.10.039_b0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1034\/j.1600-0676.2002.01503.x","article-title":"Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection","volume":"22","author":"Levy","year":"2002","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2010.10.039_b0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1872-034X.2007.00008.x","article-title":"Longitudinal analysis of murine steatohepatitis model induced by chouronic exposure to high-fat diet","volume":"37","author":"Ito","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2010.10.039_b0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine\u2013choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","author":"Rinella","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.10.039_b0140","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1440-1746.2008.05543.x","article-title":"Animal models of NASH: getting both pathology and metabolic context right","volume":"23","author":"Larter","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.10.039_b0145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.biocel.2008.10.027","article-title":"Non-alcoholic steatohepatitis and animal models: understanding the human disease","volume":"41","author":"Varela-Ray","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jhep.2010.10.039_b0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/07315724.2008.10719703","article-title":"Prevention and reversion of non-alcoholic steatohepatitis in ob\/ob mice by S-nitroso-N-acetylcysteine treatment","volume":"27","author":"de Oliveria","year":"2008","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jhep.2010.10.039_b0155","first-page":"G1035","article-title":"Obese and diabetic db\/db mice develop marked liver fibrosis in a model of non-alcoholic steatohepatitis: role of short-form leptin receptors and osteopontin","volume":"287","author":"Sahai","year":"2004","journal-title":"Am J Physiol: Gastroenterol Liver Physiol"},{"key":"10.1016\/j.jhep.2010.10.039_b0160","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/415339a","article-title":"Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase","volume":"415","author":"Minokoshi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2010.10.039_b0165","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1056\/NEJMp038239","article-title":"Causation of Type 2 diabetes \u2013 The Gordian Knot unravels","volume":"350","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.10.039_b0170","doi-asserted-by":"crossref","unstructured":"Rodrigues B, Poucheret P, Battell M, McNeill JH. STZ-induced diabetes: induction, mechanism(s) and dose-dependency. In: McNeill JH, editor. Experimental models of diabetes. Boca Raton, FL: CRC; 1999. p. 3\u201317.","DOI":"10.1201\/9780203756386-1"},{"key":"10.1016\/j.jhep.2010.10.039_b0175","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2010.10.039_b0180","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/diab.30.5.424","article-title":"A major loss in islet mass and B-cell function precedes hyperglycaemia in mice given multiple low doses of streptozotocin","volume":"30","author":"Bonnecie-Nielsen","year":"1981","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2010.10.039_b0185","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF00270421","article-title":"Multiple low dose streptozotocin-induced diabetes in the mouse: further evidence for involvement of an anti-B cell cytotoxic cellular auto-immune response","volume":"30","author":"McEvoy","year":"1987","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2010.10.039_b0190","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/bmj.328.7442.750","article-title":"Type 1 diabetes: recent developments","volume":"328","author":"Devendra","year":"2004","journal-title":"Brit Med J"},{"key":"10.1016\/j.jhep.2010.10.039_b0195","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/01480548009108283","article-title":"Toxicologic evaluation of streptozotocin (NSC85998) in mice, dogs and monkeys","volume":"3","author":"Levine","year":"1980","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.jhep.2010.10.039_b0200","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/j.1464-5491.2005.01675.x","article-title":"What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus?","volume":"22","author":"Tayebjee","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.jhep.2010.10.039_b0205","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/01.ASN.0000065640.77499.D7","article-title":"Extracellular matrix metabolism in diabetic nephropathy","volume":"14","author":"Mason","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2010.10.039_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jhep.2010.10.039_b0215","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.2337\/db09-0567","article-title":"C. elegans as model for the study of high glucose-mediated life span reduction","volume":"58","author":"Schlotterer","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2010.10.039_b0220","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1440-1746.2010.06253.x","article-title":"A fresh look at NASH pathogenesis. Part 1: The metabolic movers","volume":"25","author":"Larter","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2010.10.039_b0225","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jhep.2005.11.030","article-title":"Insulin resistance, adiponectin, cytokines in NASH: which is the best target to treat?","volume":"44","author":"Larter","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2010.10.039_b0230","doi-asserted-by":"crossref","first-page":"C1490","DOI":"10.1152\/ajpcell.00049.2009","article-title":"Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor","volume":"297","author":"Wang","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jhep.2010.10.039_b0235","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00125-007-0739-4","article-title":"Alterations in liver sinusoidal endothelium in baboon model of type 1 diabetes","volume":"50","author":"Jamieson","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2010.10.039_b0240","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1210\/en.2002-220619","article-title":"Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguandine","volume":"143","author":"Twigg","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2010.10.039_b0245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/bbrc.1996.0568","article-title":"Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells","volume":"221","author":"Sone","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2010.10.039_b0250","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/jhep.2001.28055","article-title":"High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in non-alcoholic steatohepatitis","volume":"34","author":"Paradis","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.10.039_b0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of non-alcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.10.039_b0260","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gasteroenterology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810011700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810011700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T23:36:40Z","timestamp":1592177800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827810011700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0168827810011700"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2010.10.039","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}